medicare fee-for-service (ffs) hospital utilization report · 3/29/2019 · report details - this...
TRANSCRIPT
Medicare Fee-For-Service (FFS) Hospital Utilization Report
Maryland Statewide Data
Report Date: 3/29/2019
Report Timeframe: Q4-2017 to Q3-2018
This material was prepared by Health Quality Innovators (HQI), the Medicare Quality Innovation Network-Quality Improvement Organization (QIN-QIO) for
Maryland and Virginia, with support from Telligen, the QIN National Coordinating Center, under contract with the Centers for Medicare & Medicaid Services
(CMS), an agency of the U.S. Department of Health and Human Services. The contents presented do not necessarily reflect CMS policy. HQI|11SOW|20190329-
135829
Page 1
Group/Measure Description
National/USAll Medicare fee-for-service (FFS) beneficiaries residing in any valid ZIP code in the 50 States, District of Columbia, Puerto Rico,
the United States (US) Virgin Islands, and outer Pacific islands.
State All Medicare FFS beneficiaries residing in any valid ZIP code in the state/territory.
Eligible Beneficiaries Number of Medicare FFS beneficiaries who reside in the ZIP codes associated with the designated grouping.
AdmissionsNumber of hospitalizations from short-term hospitals, critical access hospitals (CAHs), psychiatric hospitals, and psychiatric
units among eligible Medicare FFS beneficiaries who reside in the ZIP codes associated with the designated grouping.
Readmissions
Number of readmissions within 30 days of a hospital discharge among eligible Medicare FFS beneficiaries residing in the ZIP
codes associated with the designated grouping. Readmissions and hospital discharges are from short-term hospitals, CAHs,
psychiatric hospitals, and psychiatric units.
Emergency Department VisitsNumber of ED visits from short-term hospitals, CAHs, psychiatric hospitals, and psychiatric units among eligible FFS
beneficiaries residing in the ZIP codes associated with the designated grouping.
Observation StaysNumber of observation stays from short-term hospitals, CAHs, psychiatric hospitals, and psychiatric units among eligible FFS
beneficiaries residing in the ZIP codes associated with the designated grouping.
• Frequency of days until readmission broken down by return to same hospital versus other hospital
Supplemental Information on Groups and Measures
Report Details - This report contains the following data:
Summary data for yearlong timeframe (Q4-2017 through Q3-2018)
• Hospital utilization raw numbers and per 1,000 beneficiaries rates for admissions, readmissions, emergency department visits, and
observation stays comparing state to nation
• 30-day readmission rates by beneficiary demographics (gender, race/ethnicity, age group)
• 30-day readmission rates by length of stay and primary discharge destination
• Percentages of institutional days by setting, of vaccination rates, and home health services utilized
Data sources: Medicare Part A claims and QIN NCC Scorecard [Data pulled January 2019]
• Top 10 principal discharge diagnoses leading to a 30-day readmission by discharge destination
Quarterly data for three-years of time (Q4-2017 through Q3-2018)
• Rates per 1,000 beneficiaries for admissions, readmissions, emergency department visits, and observation stays comparing state
to nation, and % of live discharges readmitted within 30 days comparing state to nation
• Percent of live discharges readmitted within 30 days by primary discharge destination
• Hospital utilization (includes admissions, emergency department visits, and observation stays) and readmissions per 1,000 high-risk
medication (HRM) beneficiaries on opioids, anticoagulants, or diabetics.
• Readmission rates by discharge destination and age distribution of beneficiaries with diabetes
• Percent of live discharges readmitted within 30 days for beneficiaries with diabetes
Page 2
RAW DATA Maryland Nation Maryland Nation
# Eligible Beneficiaries 881,565 38,095,369 244.53 261.89
# Admissions 216,160 10,004,195 42.87 46.99
# Readmissions 37,899 1,794,983 334.85 383.12
# Discharges 208,982 9,694,493 70.16 54.33
# ED Visits 296,003 14,635,153 18.14% 18.52%
# Observations Stays 62,021 2,075,218
Table 2. Maryland vs. Nation Hospital Utilization Rates
Maryland Statewide Overview
(Q4-2017 to Q3-2018)
% of Live Discharges Readmitted Within 30 Days
# Observation Stays per 1,000 Beneficiaries
# ED Visits per 1,000 Beneficiaries
# Readmissions per 1,000 Beneficiaries
# Admissions per 1,000 Beneficiaries
RATES
Table 1: Maryland vs. Nation Raw Hospital Utilization Data
Page 3
Maryland Statewide Overview
(Q4-2017 to Q3-2018)
Table w/ PPV w/ flu vaccine using HHA
# eligible benes 614653 644652 881,565
# benes with X 351246 385643 179780
% with Pneumococcal Vaccination (Q4-2017 to Q3-2018)57.15%
% with Flu Vaccination (Aug2017-Mar2018)59.82%
% using HHA (Q4-2017 to Q3-2018) 20.39%
LTACHs 13,675
Rehab Units & Hospitals 43,321
Psych Units & Hospitals 49,092
Short-Term Hospital 1,411,263
SNFs & Swing Beds 2,630,684
244.53
42.87
334.85
70.16
18.14%
261.89
46.99
383.12
54.3318.52%
0.00
100.00
200.00
300.00
400.00
500.00
# Admissions per 1,000
Beneficiaries
# Readmissions per 1,000
Beneficiaries
# ED Visits per 1,000
Beneficiaries
# Observation Stays per
1,000 Beneficiaries
% of Live Discharges
Readmitted Within 30 Days
Statewide vs. National Hospital Utilization Rates (Q4-2017 to Q3-2018)
Maryland Nation
57.15%59.82%
20.39%
0%
10%
20%
30%
40%
50%
60%
70%
% with Pneumococcal
Vaccination (Q4-2017 to
Q3-2018)
% with Flu Vaccination
(Aug2017-Mar2018)
% using HHA (Q4-2017 to
Q3-2018)
% of Eligible Medicare Beneficiaries Receiving
Vaccinations and Using Home Health Services
LTACHs
0%
Rehab Units
& Hospitals
1% Psych Units
& Hospitals
1%
Short-Term
Hospital
34%
SNFs &
Swing Beds
64%
% of Medicare Institutional Days Spent by Setting
(Q4-2017 to Q3-2018)
Page 4
BENEFICIARY SEX &
RACE/ETHNICITYDischarges Readmissions Readm30%
BENEFICIARY
AGE GROUPDischarges Readmissions Readm30%
Males 93,589 17,877 19.10% Under 65 39,382 9,235 23.45%
Females 112,756 18,997 16.85% 65-69 32,218 5,405 16.78%
White 134,798 22,476 16.67% 70-74 35,278 5,819 16.49%
Black 61,238 12,657 20.67% 75-79 32,153 5,697 17.72%
Asian 3,172 548 17.28% 80-84 27,017 4,489 16.62%
Hispanic 1,853 336 18.13% 85 and Older 40,298 6,229 15.46%
Maryland Statewide Overview
(Q4-2017 to Q3-2018)
Table 3. Maryland % of Live Discharges Readmitted Within 30 Days by Demographics (Beneficiary Sex, Race/Ethnicity, and Age Group)
19.1%16.8% 16.7%
20.7%17.3% 18.1%
0%
10%
20%
30%
0
50,000
100,000
150,000
Males Females White Black Asian Hispanic
Maryland 30-Day Readmission % by Beneficiary Sex and
Race/Ethnicity
Discharges Readmissions Readm30% 23.4%
16.8% 16.5% 17.7% 16.6% 15.5%
0%
5%
10%
15%
20%
25%
0
10,000
20,000
30,000
40,000
50,000
Under 65 65-69 70-74 75-79 80-84 85 and
Older
Maryland 30-Day Readmission % by Beneficiary Age Group
Discharges Readmissions Readm30%
0
500
1000
1500
2000
2500
3000
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
Histogram of Days Until Readmission by Day and Readmit Location
Readmitted to Same Hospital Readmitted to Other Hospital
Page 5
Maryland Statewide Overview
(Q4-2017 to Q3-2018)
Length of Stay Discharges Readmissions Readm30%
1 - 3 days 94,920 13,724 14.46%
4 - 7 days 72,155 13,629 18.89% HHA 39,494 7,616 19.28%
8 - 14 days 29,313 6,828 23.29% Home 99,302 16,498 16.61%
15 - 21 days 6,743 1,653 24.51% SNF 45,683 8,861 19.40%
> 21 days 3,845 1,040 27.05% Hospice 7,147 171 2.39%
ICD-10 Code HHA Home SNF Other Total
A41.9 447 638 828 240 2,153
I13.0 400 652 319 125 1,496
J44.1 194 597 143 69 1,003
I11.0 209 470 155 86 920
N17.9 196 349 254 60 859
J18.9 180 335 179 54 748
I21.4 118 244 106 141 609
N39.0 131 199 203 45 578
J96.01 108 174 121 65 468
J96.21 131 161 119 37 448
Discharge
DestinationReadm30%ReadmissionsDischarges
Table 4. Maryland % of Live Discharges Readmitted Within
30 Days by Length of Stay
Table 5. Maryland % of Live Discharges Readmitted Within
30 Days by Primary Discharge Destination
Acute and chronic respiratory failure with hypoxia
Principal Discharge Diagnosis
Sepsis, unspecified organism
Chronic obstructive pulmonary disease, acute exacerbation
Pneumonia, unspecified organism
Acute respiratory failure with hypoxia
Hypertensive heart and chronic kidney disease with heart failure and stage 1-4 or unspecified CKD
Acute kidney failure, unspecified
Urinary tract infection, site not specified
Hypertensive heart disease with heart failure
Non-ST elevation (NSTEMI) myocardial infarction
14.5%18.9%
23.3% 24.5%27.0%
0%
10%
20%
30%
0
50,000
100,000
1 - 3 days 4 - 7 days 8 - 14 days 15 - 21 days > 21 days
Maryland Readmission % by Length of Stay
Discharges Readmissions Readm30%
19.3%16.6%
19.4%
2.4%
0%
10%
20%
30%
0
50,000
100,000
150,000
HHA Home SNF Hospice
Maryland Readmission % by Discharge Destination
Discharges Readmissions Readm30%
447
400
194
209
196
180
118
131
108
131
638
652
597
470
349
335
244
199
174
161
828
319
143
155
254
179
106
203
121
119
0 500 1,000 1,500 2,000 2,500
Sepsis, unspecified organism
Hypertensive heart and chronic kidney disease with heart failure and stage…
Chronic obstructive pulmonary disease, acute exacerbation
Hypertensive heart disease with heart failure
Acute kidney failure, unspecified
Pneumonia, unspecified organism
Non-ST elevation (NSTEMI) myocardial infarction
Urinary tract infection, site not specified
Acute respiratory failure with hypoxia
Acute and chronic respiratory failure with hypoxia
Top 10 Principal Discharge Diagnoses Leading to a 30-Day Readmission by Discharge Destination
(Q4-2017 to Q3-2018)
HHA Home SNF Other
Page 6
Readmissions per 1,000
HRM Beneficiaries
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017CY 2017
4/2017-
3/2018
7/2017-
6/2018
Hospital Utilization per
1,000 HRM Beneficiaries
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017CY 2017
4/2017-
3/2018
7/2017-
6/2018
Opioids 167.24 164.26 163.96 160.90 161.28 163.12 Opioids 1888.04 1874.70 1867.92 1869.32 1862.59 1855.45
Maryland Statewide Overview
(Q1-2017 to Q2-2018)
167.24
164.26 163.96
160.90 161.28
163.12
156
158
160
162
164
166
168
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017
CY 2017 4/2017-
3/2018
7/2017-
6/2018
Readmissions per 1,000 High-Risk Medication
Beneficiaries on Opioids
1888.04
1874.701867.92 1869.32
1862.591855.45
18301840185018601870188018901900
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017
CY 2017 4/2017-
3/2018
7/2017-
6/2018
Hospital Utilization per 1,000 High-Risk Medication
Beneficiaries on Opioids
Page 7
Maryland Statewide Overview
(Q1-2017 to Q2-2018)
Readmissions per 1,000
HRM Beneficiaries
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017CY 2017
4/2017-
3/2018
7/2017-
6/2018
Hospital Utilization per
1,000 HRM Beneficiaries
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017CY 2017
4/2017-
3/2018
7/2017-
6/2018
Anticoagulants 186.90 181.14 177.98 172.11 169.75 172.72 Anticoagulants 1676.95 1662.19 1665.35 1667.24 1651.98 1651.39
186.90
181.14177.98
172.11169.75
172.72
160
165
170
175
180
185
190
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017
CY 2017 4/2017-
3/2018
7/2017-
6/2018
Readmissions per 1,000 High-Risk Medication
Beneficiaries on Anticoagulants1676.95
1662.191665.35 1667.24
1651.98 1651.39
1630
1640
1650
1660
1670
1680
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017
CY 2017 4/2017-
3/2018
7/2017-
6/2018
Hospital Utilization per 1,000 High-Risk Medication
Beneficiaries on Anticoagulants
Page 8
Maryland Statewide Overview
(Q1-2017 to Q2-2018)
Readmissions per 1,000
HRM Beneficiaries
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017CY 2017
4/2017-
3/2018
7/2017-
6/2018
Hospital Utilization per
1,000 HRM Beneficiaries
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017CY 2017
4/2017-
3/2018
7/2017-
6/2018
Diabetics 93.88 90.94 90.11 87.07 85.27 86.99 Diabetics 1097.82 1089.60 1087.36 1081.02 1068.20 1071.87
93.88
90.94 90.11
87.0785.27
86.99
80
85
90
95
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017
CY 2017 4/2017-
3/2018
7/2017-
6/2018
Readmissions per 1,000 High-Risk Medication
Beneficiaries on Diabetics
1097.821089.60 1087.36
1081.02
1068.201071.87
1050
1060
1070
1080
1090
1100
1110
4/2016 -
3/2017
7/2016 -
6/2017
10/2016 -
9/2017
CY 2017 4/2017-
3/2018
7/2017-
6/2018
Hospital Utilization per 1,000 High-Risk Medication
Beneficiaries on Diabetics
Page 9
Table 6: REGION Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
Diabetes 20.51% 20.97% 20.56% 20.73% 20.69% 20.43% 20.19% 20.63% 20.47% 20.51% 20.75% 19.82%No Diabetes 16.57% 16.32% 15.99% 16.43% 16.25% 16.09% 15.51% 15.62% 15.99% 16.19% 16.07% 15.60%
MD Discharges Readm30 Readm30% MD Count
HHA 16,560 3,580 21.6% 21-25 24
Home 38,023 6,991 18.4% 26-30 75
SNF 20,091 4,575 22.8% 31-35 142
Hospice 2,437 72 3.0% 36-40 289
Other 6,239 1,781 28.5% 41-45 230
46-50 469
51-55 764
56-60 1,150
61-65 1,651
66-70 3,043
71-75 2,893
76-80 2,665
81-85 1,858
86-90 1,178
91-95 466
96-100 88
101-105 14
Maryland Statewide Quarterly Data
(Q4-2015 to Q3-2018)
% of Live Discharges Readmitted Within 30 Days for Beneficiaries with Diabetes
20.51%20.97% 20.56% 20.73% 20.69% 20.43% 20.19%
20.63% 20.47% 20.51% 20.75%19.82%
16.57% 16.32% 15.99%16.43% 16.25% 16.09%
15.51% 15.62% 15.99% 16.19% 16.07%15.60%
10.00%
12.00%
14.00%
16.00%
18.00%
20.00%
22.00%
Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
% of Live Discharges Readmitted Within 30 Days for Beneficiaries with Diabetes
Diabetes No Diabetes
21.6%
18.4%
22.8%
3.0%
28.5%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
HHA Home SNF Hospice Other
Maryland 30-Day Readmission % for Beneficiaries with
Diabetes
Discharges Readm30 Readm30%
0
500
1,000
1,500
2,000
2,500
3,000
3,500
21-2
5
26-3
0
31-3
5
36-4
0
41-4
5
46-5
0
51-5
5
56-6
0
61-6
5
66-7
0
71-7
5
76-8
0
81-8
5
86-9
0
91-9
5
96-1
00
101-1
05
Age Distribution of Maryland Statewide Beneficiaries with
Diabetes Readmitting Within 30 Days
Page 10
Table 7: REGION Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
Maryland 66.02 67.39 66.34 63.73 64.66 68.72 63.61 60.49 61.48 65.37 61.02 57.39Nation 67.07 69.50 67.55 65.57 66.43 71.18 67.07 64.57 65.92 69.70 64.98 62.04
Table 8:
REGION Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
Maryland 11.87 12.09 11.74 11.52 11.56 12.07 10.98 10.58 10.82 11.49 10.86 9.84Nation 12.01 12.44 12.06 11.91 11.93 12.77 12.08 11.73 11.91 12.46 11.65 11.10
Maryland Statewide Quarterly Data
(Q4-2015 to Q3-2018)
Admissions per 1,000 Beneficiaries
30-Day Readmissions per 1,000 Beneficiaries
66.0267.39 66.34
63.73 64.66
68.72
63.61
60.49 61.48
65.37
61.02
57.39
50.00
55.00
60.00
65.00
70.00
75.00
Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
Admissions per 1,000 Beneficiaries
Nation Maryland
11.87 12.0911.74 11.52 11.56
12.07
10.9810.58 10.82
11.4910.86
9.84
8.00
9.00
10.00
11.00
12.00
13.00
14.00
Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
30-Day Readmissions per 1,000 Beneficiaries
Nation Maryland
Page 11
Maryland Statewide Quarterly Data
(Q4-2015 to Q3-2018)
Table 9:
REGION Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
Maryland 86.19 81.78 86.43 88.30 83.95 84.22 87.07 87.71 83.18 82.73 84.68 85.17Nation 97.56 97.02 100.55 102.08 97.51 98.59 99.63 100.92 96.97 96.01 95.65 95.54
Table 10:
REGION Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
Maryland 16.49 16.62 16.85 16.85 16.88 17.38 17.41 17.27 17.53 17.38 18.03 17.41Nation 13.77 14.08 14.35 14.15 13.86 14.11 13.96 13.89 13.69 13.60 13.77 13.42
Observation Stays per 1,000 Beneficiaries
Emergency Department Visits per 1,000 Beneficiaries
86.1981.78
86.43 88.3083.95 84.22
87.07 87.7183.18 82.73 84.68 85.17
60.00
70.00
80.00
90.00
100.00
110.00
Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
Emergency Department Visits per 1,000 Beneficiaries
Nation Maryland
16.49 16.62 16.85 16.85 16.88 17.38 17.41 17.27 17.53 17.3818.03
17.41
8.00
10.00
12.00
14.00
16.00
18.00
20.00
Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
Observation Stays per 1,000 Beneficiaries
Nation Maryland
Page 12
Maryland Statewide Quarterly Data
(Q4-2015 to Q3-2018)
Table 11: REGION Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
Maryland 18.56% 18.58% 18.27% 18.66% 18.53% 18.20% 17.82% 18.06% 18.22% 18.24% 18.34% 17.71%
Nation 18.50% 18.53% 18.40% 18.71% 18.56% 18.55% 18.56% 18.71% 18.66% 18.52% 18.46% 18.41%
Table 12:
SETTING Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
HHA 19.96% 18.97% 19.20% 19.90% 20.31% 19.42% 19.12% 19.81% 19.13% 19.18% 19.68% 19.14%
Home 17.20% 17.46% 16.96% 17.37% 17.09% 16.72% 16.47% 16.19% 16.77% 16.50% 16.71% 16.48%
SNF 19.98% 19.86% 19.83% 19.68% 19.29% 19.56% 19.35% 19.40% 19.26% 19.94% 19.65% 18.64%
Hospice 2.87% 2.32% 2.20% 2.98% 2.83% 2.33% 2.27% 2.43% 2.79% 2.13% 2.58% 2.06%
Maryland % of Live Discharges Readmitted by Primary Discharge Destination
% of Live Discharges Readmitted Within 30 Days
18.56% 18.58%18.27%
18.66% 18.53%18.20%
17.82%18.06% 18.22% 18.24% 18.34%
17.71%
15.00%
16.00%
17.00%
18.00%
19.00%
Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
% of Live Discharges Readmitted Within 30 Days
Nation Maryland
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
Q4-2015 Q1-2016 Q2-2016 Q3-2016 Q4-2016 Q1-2017 Q2-2017 Q3-2017 Q4-2017 Q1-2018 Q2-2018 Q3-2018
Maryland % of Live Discharges Readmitted Within 30 Days by Primary Discharge Destination
HHA Home SNF Hospice
Page 13
Contact Name Position/Description Email Address Telephone #
HQI Main Office (804)289-5320
Carla Thomas Director, Care Transitions [email protected] (804)289-5318
Kelly Arthur Improvement Consultant, Care Transitions [email protected] (804)289-5344
Jennifer Igo Improvement Consultant, Care Transitions [email protected] (804)289-5333
About HQI
As the QIN-QIO for Maryland and Virginia, HQI convenes patients, providers and stakeholders to rapidly improve health quality and achieve better health,
better care and lower costs. We do this work through CMS’ QIO Program, the cornerstone of Medicare’s efforts to improve the quality and value of health
care for its more than 45 million beneficiaries. For additional information on this report or our organization, please see contact table below:
Page 14